Transaction overview
Learning Pool (GB), a global learning technology company owned by private equity firm Marlin Equity Partners, acquired WorkRamp Inc. (US) on October 15, 2025. The deal value was not disclosed but Learning Pool gained full ownership of the San Francisco-based LMS platform provider. With this acquisition, Learning Pool aims to serve a broader spectrum of customers and enhance its ability to meet diverse learning needs across industries and geographies.
Deal structure and financing
The financial details of the acquisition were not provided in public statements. Neither equity nor debt splits, lead banks involved, or leverage metrics for the transaction are available. No information was disclosed regarding seller-retained stakes or lock-up terms. The possibility of an IPO optionality for WorkRamp following the integration period remains speculative without specific announcements.
Strategic context
Learning Pool's acquisition of WorkRamp is driven by its strategic objective to expand its market reach and serve a wider range of customers, from high-growth startups to large enterprises. Learning Pool seeks to leverage WorkRamp’s intuitive LMS platform alongside its existing enterprise-grade solutions. The rationale behind the deal also highlights Marlin Equity Partners' vision for scaling Learning Pool's impact in the learning and development ecosystem.
For WorkRamp, being acquired by a larger player like Learning Pool provides an opportunity to scale operations while continuing to innovate and deliver high-quality learning experiences. Both companies share a strong culture of innovation and aim to build a comprehensive, user-friendly learning ecosystem that addresses various needs across different market segments.
Regulatory path
No specific regulatory review or filings have been mentioned for this acquisition as of October 15, 2025. Given the nature of the transaction involving cross-border entities (Learning Pool being based in GB and WorkRamp in US), it is likely that regulators from both jurisdictions would be involved if further scrutiny were necessary. However, no remedies or antitrust concerns have been disclosed at this stage, suggesting a smooth regulatory path for the deal.